Press: Important Information for Journalists
The DASGIP virtual press room is where journalists can locate press contacts or find key corporate information and images. Additional information about the company are available under Company and News.
For former press releases, articles and application notes please refer to our Press Archive. You'll also find information material on all DASGIP products.
Latest Press Release
Eppendorf acquires DASGIP Group
Hamburg/Juelich, January 5th, 2012 – Eppendorf AG today announced its acquisition of the DASGIP Group, a technology leader in the fields of bioprocess and information technology. DASGIP, with offices in Juelich, Germany, and Shrewsbury, Massachusetts, has established a high reputation as developer and manufacturer of parallel bioreactor systems and innovative control and analysis software.
Eppendorf CEO Dirk Ehlers, Ph.D., commented the transaction: „DASGIP is a strategically important addition to the Eppendorf Group. DASGIP’s high quality parallel bioreactors and software solutions nicely complement the current offering of our New Brunswick product lines. They allow us to forge a comprehensive suite of products for bioprocess research applications, development and scale up, from 30 mL to 3,000 liters. Furthermore, the advanced software concepts will position DASGIP as a strong Competence Center in these fields.”
DASGIP CEO Thomas Drescher, Ph.D., added: “The DASGIP and Eppendorf strategies and corporate cultures have an excellent fit. We look forward to combining our technical expertise with the broad range of Eppendorf lab solutions in the fields of liquid-, sample- and cell handling. DASGIP products now can be brought to all major markets worldwide with the additional sales and service force available through the regional Eppendorf organizations.”
The deal closed on January 2, 2012. Financial terms were not disclosed.
DASbox 24-fold System
Images
The following images of the DASGIP management team and the company's products are made available for reporting purposes only. These high-resolution images may be downloaded and used for the specific purpose of reporting at no charge, provided that DASGIP AG is indicated as the source.
Management Team
DASGIP Management Board (right to left):
Dr. Thomas Drescher, Chief Executive Officer
Dr. Matthias Arnold, Executive Board Member
Dr. Falk Schneider, Executive Board Member
DASGIP Supervisory Board:
Dr. Dirk H. Ehlers, Chairman
Detmar P. Ammermann, Vice Chairman
Dr. Michael Schroeder
» additional information about the management team
Products
Company Overview
DASGIP AG develops and manufactures technologically-superior parallel bioreactor systems designed for the lab-scale cultivation of bacterial, animal and human cells.
The current management board, which founded DASGIP in 1991, is headed by Dr. Thomas Drescher (President & CEO), Dr. Matthias Arnold (Chief Scientific Officer) and Dr. Falk Schneider (Executive Vice President).
The members of the supervisory board are Dr. Jürgen Kischoweit (Chairman), Rolf Geisen and Prof. Dr. Wiltrud Treffenfeldt.
The company is headquartered in Jülich, Germany. DASGIP Biotools LLC is a wholly-owned subsidiary with headquarters in Shrewsbury, MA (USA).
» additional information
Press Archive
In the press archive journalists will find a collection of articles and application notes regarding the DASGIP technology. DASGIP's press releases are available for download, as well as various information on all our products.